{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:23:58Z","timestamp":1793215438120,"version":"4.5.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jcv.2018.03.001","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T12:30:59Z","timestamp":1520253059000},"page":"84-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":467,"special_numbering":"C","title":["Primary Epstein-Barr virus infection"],"prefix":"10.1016","volume":"102","author":[{"given":"Samantha K.","family":"Dunmire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya S.","family":"Verghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Henry H.","family":"Balfour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2018.03.001_bib0005","first-page":"3","article-title":"Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study \u2013 a review","author":"de-The","year":"1975","journal-title":"IARC Sci. Publ."},{"key":"10.1016\/j.jcv.2018.03.001_bib0010","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0140-6736(64)92354-2","article-title":"Cultivation in vitro of human lymphoblasts from Burkitt's malignant lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2018.03.001_bib0015","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt's lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2018.03.001_bib0020","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1084\/jem.121.5.761","article-title":"Morphological and biological studies on a virus in cultured lymphoblasts from Burkitt's lymphoma","volume":"121","author":"Epstein","year":"1965","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jcv.2018.03.001_bib0025","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa023141","article-title":"Characteristics of Hodgkin's lymphoma after infectious mononucleosis","volume":"349","author":"Hjalgrim","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2018.03.001_bib0030","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1073\/pnas.56.6.1699","article-title":"Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells","volume":"56","author":"Old","year":"1966","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jcv.2018.03.001_bib0035","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/2281056a0","article-title":"EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx","volume":"228","author":"zur Hausen","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.jcv.2018.03.001_bib0040","first-page":"469","article-title":"Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma","volume":"139","author":"Shibata","year":"1991","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0045","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Persistence of the Epstein-Barr virus and the origins of associated lymphomas","volume":"350","author":"Thorley-Lawson","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2018.03.001_bib0050","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nrneurol.2012.198","article-title":"The initiation and prevention of multiple sclerosis","volume":"8","author":"Ascherio","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0055","first-page":"2442","article-title":"Immunofluorescence, interference, and complement fixation technics in the detection of the herpes-type virus in Burkitt tumor cell lines","volume":"27","author":"Henle","year":"1967","journal-title":"Cancer Res."},{"key":"10.1016\/j.jcv.2018.03.001_bib0060","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ana.21978","article-title":"Primary infection with the Epstein-Barr virus and risk of multiple sclerosis","volume":"67","author":"Levin","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0065","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/infdis\/jit321","article-title":"Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6\u201319 years in the United States and factors affecting its acquisition","volume":"208","author":"Balfour","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.03.001_bib0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jmv.1890150103","article-title":"The seroepidemiology of infection due to Epstein-Barr virus in southern India","volume":"15","author":"Venkitaraman","year":"1985","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/cid\/ciu342","article-title":"Age-specific prevalence of Epstein-Barr virus infection among Minnesota children: effects of race\/ethnicity and family environment","volume":"59","author":"Condon","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.03.001_bib0080","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jis646","article-title":"Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students","volume":"207","author":"Balfour","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.03.001_bib0085","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/cti.2016.48","article-title":"Prospective studies of infectious mononucleosis in university students","volume":"5","author":"Grimm","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/jinf.2002.1022","article-title":"The changing epidemiology of infectious mononucleosis","volume":"45","author":"Morris","year":"2002","journal-title":"J. Infect."},{"key":"10.1016\/j.jcv.2018.03.001_bib0095","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1440-1827.2006.01936.x","article-title":"Prevalence of Epstein-Barr virus in Japan: trends and future prediction","volume":"56","author":"Takeuchi","year":"2006","journal-title":"Pathol. Int."},{"key":"10.1016\/j.jcv.2018.03.001_bib0100","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJM196811212792101","article-title":"Seroepidemiologic studies of infectious mononucleosis with EB virus","volume":"279","author":"Evans","year":"1968","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2018.03.001_bib0105","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1001\/jama.1970.03170260036009","article-title":"A seroepidemiologic study of infectious mononucleosis: the development of EB virus antibody in a military population","volume":"212","author":"Lehane","year":"1970","journal-title":"JAMA"},{"key":"10.1016\/j.jcv.2018.03.001_bib0110","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.4.5788.643","article-title":"A Infectious mononucleosis and its relationship to EB virus antibody. A joint investigation by university health physicians and P.H.L.S. laboratories","volume":"4","year":"1971","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jcv.2018.03.001_bib0115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/infdis\/123.3.263","article-title":"Prospective studies of a group of Yale University freshmen: I. Occurrence of infectious mononucleosis","volume":"123","author":"Sawyer","year":"1971","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.03.001_bib0120","first-page":"182","article-title":"Infectious mononucleosis at the United States Military Academy: a prospective study of a single class over four years","volume":"47","author":"Hallee","year":"1974","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.jcv.2018.03.001_bib0125","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4269\/ajtmh.1990.42.380","article-title":"A prospective study of primary Epstein-Barr virus infections among university students in Hong Kong","volume":"42","author":"Dan","year":"1990","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jcv.2018.03.001_bib0130","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/infdis\/jir872","article-title":"Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma","volume":"205","author":"Piriou","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.03.001_bib0135","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/infdis\/jit093","article-title":"Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women","volume":"207","author":"Slyker","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.03.001_bib0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/00365548409068403","article-title":"Infectious mononucleosis in Greenland: a disease of the non-indigenous population","volume":"16","author":"Melbye","year":"1984","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.03.001_bib0145","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1474-4422(07)70196-5","article-title":"Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study","volume":"6","author":"Banwell","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/adc.56.1.49","article-title":"Primary Epstein-Barr virus infection in early childhood","volume":"56","author":"Krabbe","year":"1981","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.jcv.2018.03.001_bib0155","doi-asserted-by":"crossref","first-page":"e1004746","DOI":"10.1371\/journal.ppat.1004746","article-title":"Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children","volume":"11","author":"Jayasooriya","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jcv.2018.03.001_bib0160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/infdis\/jiw076","article-title":"Prospective characterization of the risk factors for transmission and symptoms of primary human herpesvirus infections among Ugandan infants","volume":"214","author":"Gantt","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.03.001_bib0165","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/infdis\/jit096","article-title":"Primary Epstein-Barr virus infection: impact of age at acquisition, coinfection, and viral load","volume":"207","author":"Balfour","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.03.001_bib0170","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00000441-195503000-00003","article-title":"The transmission of infectious mononucleosis","volume":"229","author":"Hoagland","year":"1955","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.jcv.2018.03.001_bib0175","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1086\/505400","article-title":"A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis","volume":"43","author":"Crawford","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.03.001_bib0180","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0140-6736(69)91532-3","article-title":"Association of EB-virus infection with the post-perfusion syndrome","volume":"1","author":"Gerber","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2018.03.001_bib0185","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood.V87.2.812.bloodjournal872812","article-title":"Epstein-Barr virus transmission from a blood donor to an organ transplant recipient with recovery of the same virus strain from the recipient's blood and oropharynx","volume":"87","author":"Alfieri","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2018.03.001_bib0190","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/j.1537-2995.2012.03611.x","article-title":"Transfusion-related Epstein-Barr virus infection among stem cell transplant recipients: a retrospective cohort study in children","volume":"52","author":"Trottier","year":"2012","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.jcv.2018.03.001_bib0195","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood.V71.5.1234.bloodjournal7151234","article-title":"Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation","volume":"71","author":"Shapiro","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2018.03.001_bib0200","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1097\/TP.0000000000000490","article-title":"Valganciclovir administration to kidney donors to reduce the burden of cytomegalovirus and Epstein-Barr virus transmission during transplantation","volume":"99","author":"Verghese","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2018.03.001_bib0205","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/infdis\/154.5.842","article-title":"Epstein-Barr virus infections in families: the role of children with infectious mononucleosis","volume":"154","author":"Sumaya","year":"1986","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.03.001_bib0210","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1038\/cti.2016.28","article-title":"Epstein-Barr virus dynamics in asymptomatic immunocompetent adults: an intensive 6-month study","volume":"5","author":"Johnson","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0215","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/oxfordjournals.aje.a112407","article-title":"Early acquisition of cytomegalovirus and Epstein-Barr virus antibody in several isolated Melanesian populations","volume":"105","author":"Lang","year":"1977","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0220","first-page":"442","article-title":"A population-based study of how children are exposed to saliva in KwaZulu-Natal Province, South Africa: implications for the spread of saliva-borne pathogens to children","volume":"15","author":"Butler","year":"2010","journal-title":"Trop. Med. Int. Health."},{"key":"10.1016\/j.jcv.2018.03.001_bib0225","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0090-1229(84)90029-1","article-title":"Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis","volume":"30","author":"Svedmyr","year":"1984","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0230","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1086\/491740","article-title":"A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis","volume":"192","author":"Balfour","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.03.001_bib0235","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/000992287201100711","article-title":"Penicillin-related exanthems in infectious mononucleosis identical to those associated with ampicillin","volume":"11","author":"Balfour","year":"1972","journal-title":"Clin. Pediatr. (Phila.)"},{"key":"10.1016\/j.jcv.2018.03.001_bib0240","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1182\/blood.V57.5.933.bloodjournal575933","article-title":"Clinical and laboratory evaluation of infants and children with Epstein-Barr virus-induced infectious mononucleosis: report of 32 patients (aged 10\u201348 months)","volume":"57","author":"Horwitz","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2018.03.001_bib0245","first-page":"19","article-title":"Review of the clinical manifestations, laboratory findings, and complications of infectious mononucleosis","volume":"84","author":"White","year":"1985","journal-title":"Wis. Med. J."},{"key":"10.1016\/j.jcv.2018.03.001_bib0250","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0887-8994(94)90021-3","article-title":"Neurologic complications of infectious mononucleosis","volume":"10","author":"Connelly","year":"1994","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0255","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00008480-200006000-00016","article-title":"Acute complications of Epstein-Barr virus infectious mononucleosis","volume":"12","author":"Jenson","year":"2000","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.jcv.2018.03.001_bib0260","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.7326\/0003-4819-46-6-1184","article-title":"Splenic rupture in infectious mononucleosis","volume":"46","author":"Hoagland","year":"1957","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jcv.2018.03.001_bib0265","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/JSM.0b013e31817e34f8","article-title":"Mononucleosis and athletic participation: an evidence-based subject review","volume":"18","author":"Putukian","year":"2008","journal-title":"Clin. J. Sport Med."},{"key":"10.1016\/j.jcv.2018.03.001_bib0270","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijid.2007.10.005","article-title":"Acute acalculous cholecystitis during the course of primary Epstein-Barr virus infection: a new case and a review of the literature","volume":"12","author":"Iaria","year":"2008","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.03.001_bib0275","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.msard.2017.06.002","article-title":"EBV and MS: Major cause, minor contribution or red-herring?","volume":"16","author":"Burnard","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jcv.2018.03.001_bib0280","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1017\/S0950268811002457","article-title":"Evidence of genetic susceptibility to infectious mononucleosis: a twin study","volume":"140","author":"Hwang","year":"2012","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.jcv.2018.03.001_bib0285","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/cid\/ciu204","article-title":"A genetic basis for infectious mononucleosis: evidence from a family study of hospitalized cases in Denmark","volume":"58","author":"Rostgaard","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.03.001_bib0290","series-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis","article-title":"Gammaherpesviruses entry and early events during infection","author":"Chandran","year":"2007"},{"key":"10.1016\/j.jcv.2018.03.001_bib0295","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1128\/JVI.00445-07","article-title":"Epstein-Barr virus entry","volume":"81","author":"Hutt-Fletcher","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0300","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","article-title":"Epstein-Barr virus: exploiting the immune system","volume":"1","author":"Thorley-Lawson","year":"2001","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0305","series-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis","article-title":"EBV gene expression and regulation","author":"Young","year":"2007"},{"key":"10.1016\/j.jcv.2018.03.001_bib0310","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1002\/j.1460-2075.1987.tb02568.x","article-title":"Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells","volume":"6","author":"Rowe","year":"1987","journal-title":"EMBO J."},{"key":"10.1016\/j.jcv.2018.03.001_bib0315","doi-asserted-by":"crossref","first-page":"e1005286","DOI":"10.1371\/journal.ppat.1005286","article-title":"The incubation period of primary Epstein-Barr virus infection: viral dynamics and immunologic events","volume":"11","author":"Dunmire","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jcv.2018.03.001_bib0320","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1128\/JVI.01677-16","article-title":"The long and complicated relationship between Epstein-Barr virus and epithelial cells","volume":"91","author":"Hutt-Fletcher","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0325","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1128\/JVI.78.10.5194-5204.2004","article-title":"Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells","volume":"78","author":"Hochberg","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0330","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1128\/JVI.18.1.151-155.1976","article-title":"Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid","volume":"18","author":"Summers","year":"1976","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0335","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/JVI.31.3.590-595.1979","article-title":"Epstein-Barr virus DNA is amplified in transformed lymphocytes","volume":"31","author":"Sugden","year":"1979","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0340","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1128\/JVI.64.9.4084-4092.1990","article-title":"Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes","volume":"64","author":"Sample","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0345","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jcv.2006.03.004","article-title":"Cytomegalovirus and Epstein-Barr virus subtypes\u2013the search for clinical significance","volume":"36","author":"Puchhammer-Stockl","year":"2006","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0350","doi-asserted-by":"crossref","first-page":"e85422","DOI":"10.1371\/journal.pone.0085422","article-title":"Primary EBV infection induces an expression profile distinct from other viruses but similar to hemophagocytic syndromes","volume":"9","author":"Dunmire","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2018.03.001_bib0355","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/infdis\/jiv340","article-title":"Cytokine-mediated loss of blood dendritic cells during Epstein-Barr virus-associated acute infectious mononucleosis: implication for immune dysregulation","volume":"212","author":"Panikkar","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.03.001_bib0360","doi-asserted-by":"crossref","first-page":"e01667","DOI":"10.1128\/JVI.01667-16","article-title":"MicroRNAs of Epstein-Barr virus control innate and adaptive antiviral immunity","volume":"91","author":"Albanese","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0365","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.4049\/jimmunol.1501605","article-title":"EBV MicroRNA BART16 suppresses type I IFN signaling","volume":"198","author":"Hooykaas","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0370","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.4049\/jimmunol.1303211","article-title":"Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus","volume":"192","author":"Hendricks","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0375","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood-2014-01-553024","article-title":"Role for early-differentiated natural killer cells in infectious mononucleosis","volume":"124","author":"Azzi","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2018.03.001_bib0380","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.celrep.2013.11.041","article-title":"Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection","volume":"5","author":"Chijioke","year":"2013","journal-title":"Cell. Rep."},{"key":"10.1016\/j.jcv.2018.03.001_bib0385","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1164\/ajrccm.162.supplement_3.15tac4","article-title":"Gammadelta cells and the regulation of mucosal immune responses","volume":"162","author":"Hayday","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jcv.2018.03.001_bib0390","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coi.2005.11.007","article-title":"The function of gammadelta T cells in innate immunity","volume":"18","author":"Born","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0395","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1084\/jem.20161017","article-title":"Two alternate strategies for innate immunity to Epstein-Barr virus: one using NK cells and the other NK cells and gammadelta T cells","volume":"214","author":"Djaoud","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jcv.2018.03.001_bib0400","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","article-title":"Cellular responses to viral infection in humans: lessons from Epstein-Barr virus","volume":"25","author":"Hislop","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0405","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1084\/jem.20121437","article-title":"MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response","volume":"210","author":"Long","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jcv.2018.03.001_bib0410","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00000441-193201000-00010","article-title":"The presence of heterophile antibodies in infectious mononucleosis","volume":"183","author":"Paul","year":"1932","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.jcv.2018.03.001_bib0415","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/ajcp\/72.5.807","article-title":"Persistent falsely positive rapid tests for infectious mononucleosis. Report of five cases with four\u2013six-year follow-up data","volume":"72","author":"Horwitz","year":"1979","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0420","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1128\/JCM.42.9.4411.2004","article-title":"False-positive result provided by rapid heterophile antibody test in a case of acute infection with hepatitis E virus","volume":"42","author":"Fisher","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0425","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/jcp.29.9.841","article-title":"Measurement of heterophil antibody and antibodies to EB viral capsid antigen IgG and IgM in suspected cases of infectious mononucleosis","volume":"29","author":"Blake","year":"1976","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0430","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1128\/CVI.00754-13","article-title":"Performance of the architect EBV antibody panel for determination of Epstein-Barr virus infection stage in immunocompetent adolescents and young adults with clinical suspicion of infectious mononucleosis","volume":"21","author":"Guerrero-Ramos","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0435","first-page":"223","article-title":"Simplicity through complexity: immunoblot with recombinant antigens as the new gold standard in Epstein-Barr virus serology","volume":"47","author":"Bauer","year":"2001","journal-title":"Clin. Lab."},{"key":"10.1016\/j.jcv.2018.03.001_bib0440","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(05)66553-1","article-title":"Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials","volume":"365","author":"Hodson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2018.03.001_bib0445","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/0003-4819-143-12-200512200-00005","article-title":"Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients","volume":"143","author":"Kalil","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jcv.2018.03.001_bib0450","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/01.tp.0000202724.07714.a2","article-title":"A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder","volume":"81","author":"Humar","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2018.03.001_bib0455","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/01.tp.0000265914.16491.7d","article-title":"Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein-Barr virus infection than younger renal transplant recipients","volume":"83","author":"Smith","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2018.03.001_bib0460","first-page":"171","article-title":"First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen","volume":"84","author":"Gu","year":"1995","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.jcv.2018.03.001_bib0465","first-page":"889","article-title":"Smallpox vaccine: contraindications, administration, and adverse reactions","volume":"68","author":"Maurer","year":"2003","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.jcv.2018.03.001_bib0470","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0264-410X(98)00248-5","article-title":"Expression of Epstein-Barr virus gp350 as a single chain glycoprotein for an EBV subunit vaccine","volume":"17","author":"Jackman","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2018.03.001_bib0475","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1016\/j.vaccine.2015.10.024","article-title":"Identification of the critical attribute(s) of EBV gp350 antigen required for elicitation of a neutralizing antibody response in vivo","volume":"33","author":"Servat","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2018.03.001_bib0480","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1016\/j.vaccine.2007.04.008","article-title":"Phase I\/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults","volume":"25","author":"Moutschen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2018.03.001_bib0485","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","article-title":"Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults","volume":"196","author":"Sokal","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.03.001_bib0490","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/TP.0b013e3181b9d918","article-title":"A phase I trial of Epstein-Barr virus gp350 vaccine for children with chronic kidney disease awaiting transplantation","volume":"88","author":"Rees","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2018.03.001_bib0495","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1128\/JVI.01409-07","article-title":"Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis","volume":"82","author":"Elliott","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0500","first-page":"CD004402","article-title":"Steroids for symptom control in infectious mononucleosis (review)","volume":"3","author":"Candy","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jcv.2018.03.001_bib0505","first-page":"1","article-title":"A method for evaluating antiviral drug susceptibility of Epstein-Barr virus","volume":"2","author":"Romain","year":"2010","journal-title":"Virus Adapt. Treat."},{"key":"10.1016\/j.jcv.2018.03.001_bib0510","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcv.2007.02.002","article-title":"A virologic pilot study of valacyclovir for infectious mononucleosis","volume":"39","author":"Balfour","year":"2007","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0515","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/ajt.14603","article-title":"Comprehensive review of post-organ transplant hematologic cancers","volume":"18","author":"Dharnidharka","year":"2018","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2018.03.001_bib0520","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/TP.0000000000000354","article-title":"The impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study","volume":"99","author":"Verghese","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2018.03.001_bib0525","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/modpathol.3880035","article-title":"The world health organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997","volume":"13","author":"Harris","year":"2000","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jcv.2018.03.001_bib0530","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1111\/j.1600-6143.2006.01543.x","article-title":"Retransplantation after post-transplant lymphoproliferative disorders: an OPTN\/UNOS database analysis","volume":"6","author":"Johnson","year":"2006","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2018.03.001_bib0535","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1399-0012.2012.01608.x","article-title":"Quantitative Epstein-Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder","volume":"26","author":"Holman","year":"2012","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.jcv.2018.03.001_bib0540","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/ajt.14020","article-title":"The role of antiviral prophylaxis for the prevention of Epstein-Barr virus-associated posttransplant lymphoproliferative disease in solid organ transplant recipients: a systematic review","volume":"17","author":"AlDabbagh","year":"2017","journal-title":"Am. J. Transplant."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653218300635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653218300635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T15:15:17Z","timestamp":1719846917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653218300635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":108,"alternative-id":["S1386653218300635"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2018.03.001","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Epstein-Barr virus infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2018.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}